Contact Us
中文
日本語
한국어
Careers
Menu
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Events
News
Posts
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Events
News
Posts
About Us
Gene Editing Services
In vivo Animal and Cell Models
RenMice™ Platforms
Efficacy & Toxicity Studies
Preclinical & Clinical Assets
Contact Us Online!
Menu
About Us
Our Sites
Executive Leadership
Gene Editing
By Technologies
CRISPR/EGE™-based Gene Editing
ESC-Based Gene Editing
Transgenic Technology
Other Services
By Strategies
Conventional Knockout/Knockin
Conditional Knockout/Knockin
Point Mutation Knockin
Rosa26 Locus Knockin
Tag and Reporter Genes
Tol2 Transgenic Mouse Model
Animal & Cell Models
Animal Models
Humanized Immune-Checkpoint Mice
Humanized Cytokine Mice
Humanized GPCR Mice
Other Humanized Models
Immunodeficient Mice (B-NDG background)
Immunodeficient Mouse Models (Non B-NDG background)
Reporter Models
Cre Mouse/Rat Models
DTR Models
Other Tool Models
Disease Mouse Models
Drug Target Knockout Mouse Models
Other Knockout Mouse Models
Cell Lines
Humanized Tumor Cell Lines
Other Cancer Cell Lines
Efficacy & Toxicity Studies
Inflammatory Disease Modeling
Psoriasis Model
Atopic Dermatitis Model
Delayed type hypersensitivity model
Acute Lung Injury & Inflammation Models
Asthma Model
Bleomycin-Induced Pulmonary Fibrosis Model
Rheumatoid Arthritis Model
Ovariectomy (OVX) induced Osteoporosis Model
Osteoarthritis Model
EAE Model
LPS Mouse Model of Acute Inflammation
Inflammatory Bowel Disease Model
Systemic Lupus Erythematosus Model
5/6 Nephrectomy Chronic Kidney Disease Model
Metabolic Disease Modeling
NASH Mouse Models
Carbon Tetrachloride (CCl4)-induced Model
HFMCD induced NASH Model
STZ-HFD NASH model
GAN model
High-fat diet-induced obese (DIO) mouse model
Spontaneous diabetes model
STZ model
Bile duct ligation-induced liver fibrosis Mouse Model
TAA (Thioacetamide) -induced liver fibrosis Mouse Model
Acetaminophen-induced Liver Injury Model
Concanavalin A hepatitis model
Atherosclerosis model
In Vivo Pharmacology Services
Syngeneic Tumor Models for Antibody Screening
CAR-T Efficacy Evaluation
Anti-Tumor Efficacy in CDX & Humanized Models
PK/PD Assays & In vitro Pharmacology Studies
Efficacy & Toxicity Case Studies
RenMice™ Platforms
Monoclonal Antibody Platform
BsAb Discovery Platform
Bispecific ADC Platform
Nanobody Platform
TCR-Mimic Antibody Platform
Anti-GPCR Antibody Technology Platform
Preclinical & Clinical Assets
Antibody Hits Library
Agonistic anti-CD40 IgG2 antibody YH003
Anti-CTLA-4 IgG1 monoclonal antibody YH001
Anti-OX40 IgG1 antibody YH002
Agonistic anti-4-1BB IgG1 antibody YH004
Anti-PD-1 x CD40 bispecific antibody YH008
HER2 x TROP2 bispecific ADC YH012
Antagonistic anti-CD40 fully human antibody YH015
Careers
News & Resources
News
Events
Brochures
Posters
Publications
Webinars
Posts
FAQs
Investors
Menu
Mettl3-mediated m6A RNA methylation regulates the fate of bone marrow
Home
News & Resources
Publications
Mettl3-mediated m6A RNA methylation regulates the fate of bone marrow
Mettl3-mediated m6A RNA methylation regulates the fate of bone marrow
Read entire article
Share:
Search
Double Opt-in by Forge12
